EFSD / Novo Nordisk Foundation Future Leaders Award Programme
Deadline Date: 1 March 2022
About the EFSD: The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application.
About the Novo Nordisk Foundation: The Novo Nordisk Foundation is an independent Danish foundation with corporate interests. The Foundation has two objectives: 1) to provide a stable basis for the commercial and research activities of the companies in the Novo Group; and 2) to support scientific, humanitarian and social causes.
The vision of the Foundation is to contribute significantly to research and development that improves the lives of people and the sustainability of society. Since 2010, the Foundation has awarded grants totalling more than DKK 20 billion (€2.7 billion), primarily for research at public institutions and hospitals in Denmark and the other Nordic countries as well as research-based treatment and prevention of diabetes.
Rationale and Intended Purpose
Young investigators face a major challenge in the transition from postdoctoral/clinical fellow to their first tenured faculty position. It is hard to gain significant and truly independent funding at this career stage, yet such support is critical to advance up the academic ladder, especially in Europe. Action is needed now to avoid a generation gap that would severely compromise future European excellence in diabetes research.
The EFSD/Novo Nordisk Foundation Future Leaders Award Programme is intended to
Candidates for an EFSD/Novo Nordisk Foundation Future Leaders Award will already have a track record of excellence and achievement in their chosen area of diabetes research. They must demonstrate through their published work (with clear indication of the role of the applicant), previous competitive (national and international) funding, membership of editorial boards, teaching and extra-curricular activities and any other relevant information that they have the aim and potential to become part of the next generation of leaders in European diabetes research.
Applications can be made by any paid-up member of EASD having received their highest academic degree (PhD, MD) not more than 10 years before the start of the award but not yet holding a tenured academic Faculty appointment. For clinicians holding more than one qualifying degree (e.g. MD PhD) or with a clinical specialist degree/board certification, the time since the first degree may not exceed 12 years before the start of the award. Time periods spent on maternity/paternity leave, military service, long-term illness or other exceptional circumstances will be taken into account, if clearly described (further documentation may be requested at the discretion of EFSD).
Candidates must work in a non-for-profit institution in any country in the European region and its associated States throughout the tenure of the grant, and should provide clear evidence of their intention to pursue an academic career in Europe (for detailed country list, please see here).
Four awards will be made each year. EFSD and the Novo Nordisk Foundation reserve the right to predetermine the respective number of clinical and basic scientists receiving awards.
Awards will be of 5 year duration subject to satisfactory progress.
Awards (to both clinicians and basic scientists) will be made in a total amount of Danish Kroner (DKK) 5 million (~ €670,000) to be paid to the awardee’s institution in 5 annual installments of DKK 1 million (~ €130,000).
Depending on individual needs and as justified in a detailed budget, funds may be used to cover part or all of the awardee’s salary, other salaries (i.e. technician or postdoctoral fellow) and direct research expenses.
The Grant may include Administrative Support, which constitutes an amount of up to 5% of the total Grant to cover expenses related to the administration of the Grant, specifically regarding accounting, controlling, auditing and reporting. No Overheads will be granted.
The first annual installment will be payable in full at the start of the award.
In subsequent years, awardees will submit an annual scientific progress report 2 months before termination of each funding year to EFSD. This will be evaluated by the Review Committee and continued funding will be dependent upon satisfactory scientific progress and involvement in recommended associated activities (see below). In the event of unsatisfactory performance, EFSD and the Novo Nordisk Foundation may decide to terminate funding.
In addition, every year, awardees will submit a report on the project outcomes to EFSD and in addition to the Novo Nordisk Foundation. These reports on the longer term outcomes of the Award, and specifically on the awardee’s academic career will be submitted for up to five years after the project has finished.
Awardees are required to submit a final scientific and financial report at the end of their award.
Associated Activities and Recognition
All awardees will be expected to serve as ambassadors for the Programme throughout the course of their award. This may include but not necessarily be limited to:
Awardees are also expected to participate in the EASD Annual Meeting in the year of the award to make a first personal connection with EFSD and Novo Nordisk Foundation representatives.
All applications must include:
All written applications will be reviewed by a fully independent committee of experts (the Review Committee). Applications may be subjected to pre-review (or triage) procedures where all applications will be reviewed and scored by up to three members of the Review Committee who have declared no conflict of interest. The most competitive (highest scored applications) will be taken forward to full review. Only candidates reaching the full review stage will receive a written critique.
Based on evaluation of the written application, the Review Committee will draw up a shortlist of leading candidates for teleconference interview and final funding decisions will be based on evaluation of the written application and performance at interview.
The deadline for receipt of applications for funding this year is 1 March 2022.
All budgets are to be prepared in DKK. Awards will be payable in this same currency and will NOT be adjusted for any alteration in the exchange rate between DKK and the local currency in the place of the award. The exchange rate (between DKK and the local currency) used for calculating the DKK budget must be mentioned under “Budget Justification”.
Application forms may be downloaded here:
All applications must be prepared on the official application form and completed in strict accordance with the detailed instructions to be found on these forms. Applications which do not comply with the instructions given in the application form will not be considered for review.
Please send your applications as one complete PDF email attachment to firstname.lastname@example.org by 12:00 midday (CET) on the deadline date 1 March 2022.
Applications will be evaluated by the Review Committee in accordance with the following criteria (in no particular order):
The award must be acknowledged in all publications, scientific presentations or participation in any of the above activities as: “Supported by an EFSD/Novo Nordisk Foundation Future Leaders Award” and through a unique Novo Nordisk Foundation grant number.
Administration and funding
The Programme will be administered by EFSD, including the application, review and yearly evaluation processes.
Awards will be paid to the awardee’s institution by the Novo Nordisk Foundation.
|Application Deadline||1 March 2022|
|Anticipated Award||July 2022|
Enquiries should be directed to: email@example.com.